Point of Care Diagnostics Market by Product, End-user, and Geography - Forecast and Analysis 2022-2026
- Published: Sep 2022
- Pages: 160
- SKU: IRTNTR45755
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
The point of care diagnostics market share is expected to increase by USD 13.09 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 10.41%.
This point of care (POC) diagnostics market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers point of care diagnostics market segmentation by product (haematology diagnostics, infectious disease diagnostics, rapid cardiovascular diagnostics, rapid coagulation diagnostics, and others), end-user (hospitals and clinics, homecare settings, and clinical diagnostic laboratories), and geography (North America, Europe, Asia, and Rest of World (ROW)). The point of care (POC) diagnostics market report also offers information on several market vendors, including Abaxis Inc, Abbott Laboratories, altona Diagnostics GmbH, Becton Dickinson and Co., bioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., Johnson and Johnson, Meridian Bioscience Inc., Nova Biomedical Corp., PerkinElmer Inc., PTS Diagnostics, QIAGEN NV, Sekisui Chemical Co. Ltd., Siemens AG, Trinity Biotech Plc, and Trivida Health Inc. among others.
What will the Point of Care Diagnostics Market Size be During the Forecast Period?
Download Report Sample to Unlock the Point of Care Diagnostics Market Size for the Forecast Period and Other Important Statistics
POC Diagnostics Market: Key Drivers, Trends, and Challenges
Based on our research output, there has been a neutral impact on the market growth during and post-COVID-19 era. The growing geriatric population is notably driving the point of care (POC) diagnostics market growth, although factors such as product recall negatively affecting sales of products may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the point of care diagnostics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key POC Diagnostics Market Driver
One of the key factors driving growth in the point of care (POC) diagnostics market is the growing geriatric population. Owing to the absence of physical activity and improper diet, people across the world are experiencing adverse effects on their health, which leads to major medical problems. These medical problems are more prevalent in geriatric people than in younger people. The geriatric population is increasing significantly across the world. The prevalence of diseases such as lung disease, cancer, and stroke is high among the aging population. There is a direct relationship between aging and susceptibility to infections as the immune system deteriorates with age. The rise in the aging population has resulted in increased expenditure on healthcare for health check-ups, disease diagnosis, and treatment. The elderly require diagnostic testing regularly due to their low immunity and metabolism. These factors have increased the demand for POC diagnostic devices as these devices assist in disease diagnosis. Hence, the increasing aging population indicates a growing demand for POC diagnostic devices, thus contributing to market growth in the coming years.
Key POC Diagnostics Market Trend
The technological advances in diagnostics is a point of care (POC) diagnostics market trend that is expected to have a positive impact in the coming years. In recent years, the global POC diagnostics market has witnessed significant developments, with diagnostic devices becoming portable, customary focal research centers moving close to patient locales, and growing test menus owing to the increased adoption of multiparameter monitoring devices. The implementation of laboratory functions in portable systems has led to a standard shift in the diagnostics field. Miniaturization of technology aids individual living cells and small volumes of reagents to be quantified on portable systems. Sensors, microsystems, and low-cost imaging technologies have been developed for POC testing. These instruments combine multiple analytical functions into self-contained, portable devices to detect and diagnose diseases. They enable the selection of optimal therapies through screening and monitoring a patient's response to a specific treatment. Thus, considering these factors, the demand for POC diagnostic products is set to positively affect the market.
Key POC Diagnostics Market Challenge
Product recalls negatively affecting sales of products will be a major challenge for the point of care (POC) diagnostics market during the forecast period. Product recalls can affect a company's revenue, as well as its long-term growth prospects. They affect consumer confidence and the company's brand image, in turn, affecting the sales of their products. Product recalls not only affect the sales of the manufacturers but also affect the operations for a longer duration, as a detailed investigation must be done to find out the cause of faultiness. The Food and Drug Administration (FDA) recalls a product if it represents a potential health risk for users or if it leads to any patient injury or fatalities. There have been instances of device recalls in the global POC diagnostics market. These instances could lead to a significant loss for vendors, thus hindering the growth of the global POC diagnostics market.
This point of care diagnostics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Parent Market Analysis
Technavio categorizes the global point of care (POC) diagnostics market as a part of the global life science tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the point of care diagnostics market during the forecast period.
Who are the Major POC Diagnostics Market Vendors?
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
- Abaxis Inc
- Abbott Laboratories
- altona Diagnostics GmbH
- Becton Dickinson and Co.
- bioMerieux SA
- Chembio Diagnostics Inc.
- Danaher Corp.
- DiaSorin SpA
- EKF Diagnostics Holdings Plc
- F. Hoffmann La Roche Ltd.
- Johnson and Johnson
- Meridian Bioscience Inc.
- Nova Biomedical Corp.
- PerkinElmer Inc.
- PTS Diagnostics
- QIAGEN NV
- Sekisui Chemical Co. Ltd.
- Siemens AG
- Trinity Biotech Plc
- Trivida Health Inc.
This statistical study of the point of care (POC) diagnostics market encompasses successful business strategies deployed by the key vendors. The point of care diagnostics market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.
Product Insights and News
-
abbott.com - The company offers point of care diagnostic solutions with simple step-by-step instructions using a nasal swab, and can be used for all ages.
-
abbott.com - Under the established pharmaceuticals products segment, the company manufactures branded generic pharmaceuticals for established and emerging markets.
To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The point of care (POC) diagnostics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
POC Diagnostics Market Value Chain Analysis
Our report provides extensive information on the value chain analysis for the point of care (POC) diagnostics market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
Which are the Key Regions for POC Diagnostics Market?
For more insights on the market share of various regions Request PDF Sample now!
38% of the market’s growth will originate from North America during the forecast period. US and Canada are the key markets for point of care diagnostics in North America. Market growth in this region will be faster than the growth of the market in the ROW regions.
The rising prevalence of such chronic diseases will facilitate the point of care (POC) diagnostics market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The COVID-19 pandemic in 2020 had a significant negative impact on the majority of North American nations. During the pandemic, there was a spike in demand for POC diagnostic tools such as analyzers since these devices are utilized to track and access the health of patients who were diagnosed with COVID-19. Medical professionals were able to quickly identify individuals who might need additional care with the help of POC technologies that provide quick data.
What are the Revenue-generating Product Segments in the POC Diagnostics Market?
To gain further insights on the market contribution of various segments Request PDF Sample
The point of care (POC) diagnostics market share growth in the hematology diagnostics segment will be significant during the forecast period. The global POC diagnostics market is fragmented, with several global and regional vendors that have established a strong foothold in diversified geographic regions globally. They focus on developing advanced, high-quality products for POC diagnostics to cater to end users' demands, such as hospitals and clinics, home care settings, and clinical diagnostic laboratories. Key vendors in the global POC diagnostics market are trying to build a strong customer base by distributing their products through their widespread distribution networks worldwide, remain competitive, and garner significant market revenue.
This report provides an accurate prediction of the contribution of all the segments to the growth of the point of care diagnostics market size and actionable market insights on the post-COVID-19 impact on each segment.
POC Diagnostics Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 10.41% |
Market growth 2022-2026 |
$13.09 billion |
Market structure |
Fragmented |
YoY growth (%) |
10.19 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 38% |
Key consumer countries |
US, Canada, Germany, UK, Japan, and China |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Abaxis Inc, Abbott Laboratories, altona Diagnostics GmbH, Becton Dickinson and Co., bioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., Johnson and Johnson, Meridian Bioscience Inc., Nova Biomedical Corp., PerkinElmer Inc., PTS Diagnostics, QIAGEN NV, Sekisui Chemical Co. Ltd., Siemens AG, Trinity Biotech Plc, and Trivida Health Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Data Covered in this POC Diagnostics Market Report?
- CAGR of the market during the forecast period 2022-2026
- Detailed information on factors that will drive point of care diagnostics market growth during the next five years
- Precise estimation of the point of care diagnostics market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the point of care diagnostics industry across North America, Europe, Asia, and Rest of World (ROW)
- A thorough analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of point of care diagnostics market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 14: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 18: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 19: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 20: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 21: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 22: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 23: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 24: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Product
- 5.1 Market segments
- Exhibit 25: Chart on Product - Market share 2021-2026 (%)
- Exhibit 26: Data Table on Product - Market share 2021-2026 (%)
- 5.2 Comparison by Product
- Exhibit 27: Chart on Comparison by Product
- Exhibit 28: Data Table on Comparison by Product
- 5.3 Hematology diagnostics - Market size and forecast 2021-2026
- Exhibit 29: Chart on Hematology diagnostics - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Data Table on Hematology diagnostics - Market size and forecast 2021-2026 ($ million)
- Exhibit 31: Chart on Hematology diagnostics - Year-over-year growth 2021-2026 (%)
- Exhibit 32: Data Table on Hematology diagnostics - Year-over-year growth 2021-2026 (%)
- 5.4 Infectious disease diagnostics - Market size and forecast 2021-2026
- Exhibit 33: Chart on Infectious disease diagnostics - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Data Table on Infectious disease diagnostics - Market size and forecast 2021-2026 ($ million)
- Exhibit 35: Chart on Infectious disease diagnostics - Year-over-year growth 2021-2026 (%)
- Exhibit 36: Data Table on Infectious disease diagnostics - Year-over-year growth 2021-2026 (%)
- 5.5 Rapid cardiovascular diagnostics - Market size and forecast 2021-2026
- Exhibit 37: Chart on Rapid cardiovascular diagnostics - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Data Table on Rapid cardiovascular diagnostics - Market size and forecast 2021-2026 ($ million)
- Exhibit 39: Chart on Rapid cardiovascular diagnostics - Year-over-year growth 2021-2026 (%)
- Exhibit 40: Data Table on Rapid cardiovascular diagnostics - Year-over-year growth 2021-2026 (%)
- 5.6 Rapid coagulation diagnostics - Market size and forecast 2021-2026
- Exhibit 41: Chart on Rapid coagulation diagnostics - Market size and forecast 2021-2026 ($ million)
- Exhibit 42: Data Table on Rapid coagulation diagnostics - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Chart on Rapid coagulation diagnostics - Year-over-year growth 2021-2026 (%)
- Exhibit 44: Data Table on Rapid coagulation diagnostics - Year-over-year growth 2021-2026 (%)
- 5.7 Others - Market size and forecast 2021-2026
- Exhibit 45: Chart on Others - Market size and forecast 2021-2026 ($ million)
- Exhibit 46: Data Table on Others - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Chart on Others - Year-over-year growth 2021-2026 (%)
- Exhibit 48: Data Table on Others - Year-over-year growth 2021-2026 (%)
- 5.8 Market opportunity by Product
- Exhibit 49: Market opportunity by Product ($ million)
6 Market Segmentation by End-user
- 6.1 Market segments
- Exhibit 50: Chart on End-user - Market share 2021-2026 (%)
- Exhibit 51: Data Table on End-user - Market share 2021-2026 (%)
- 6.2 Comparison by End-user
- Exhibit 52: Chart on Comparison by End-user
- Exhibit 53: Data Table on Comparison by End-user
- 6.3 Hospitals and clinics - Market size and forecast 2021-2026
- Exhibit 54: Chart on Hospitals and clinics - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Hospitals and clinics - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Hospitals and clinics - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Hospitals and clinics - Year-over-year growth 2021-2026 (%)
- 6.4 Homecare settings - Market size and forecast 2021-2026
- Exhibit 58: Chart on Homecare settings - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Homecare settings - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Homecare settings - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Homecare settings - Year-over-year growth 2021-2026 (%)
- 6.5 Clinical diagnostic laboratories - Market size and forecast 2021-2026
- Exhibit 62: Chart on Clinical diagnostic laboratories - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Clinical diagnostic laboratories - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Clinical diagnostic laboratories - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Clinical diagnostic laboratories - Year-over-year growth 2021-2026 (%)
- 6.6 Market opportunity by End-user
- Exhibit 66: Market opportunity by End-user ($ million)
7 Customer Landscape
- 7.1 Customer landscape overview
- Exhibit 67: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
- 8.1 Geographic segmentation
- Exhibit 68: Chart on Market share by geography 2021-2026 (%)
- Exhibit 69: Data Table on Market share by geography 2021-2026 (%)
- 8.2 Geographic comparison
- Exhibit 70: Chart on Geographic comparison
- Exhibit 71: Data Table on Geographic comparison
- 8.3 North America - Market size and forecast 2021-2026
- Exhibit 72: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 73: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 74: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 75: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 8.4 Europe - Market size and forecast 2021-2026
- Exhibit 76: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 77: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 78: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 79: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 8.5 Asia - Market size and forecast 2021-2026
- Exhibit 80: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 81: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 82: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 83: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 8.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 84: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 85: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 86: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 87: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 8.7 US - Market size and forecast 2021-2026
- Exhibit 88: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 89: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 90: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 91: Data Table on US - Year-over-year growth 2021-2026 (%)
- 8.8 Canada - Market size and forecast 2021-2026
- Exhibit 92: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 93: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 94: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 95: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 8.9 Germany - Market size and forecast 2021-2026
- Exhibit 96: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 97: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 98: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 99: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 8.10 UK - Market size and forecast 2021-2026
- Exhibit 100: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 101: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 102: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 103: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 8.11 Japan - Market size and forecast 2021-2026
- Exhibit 104: Chart on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 105: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 106: Chart on Japan - Year-over-year growth 2021-2026 (%)
- Exhibit 107: Data Table on Japan - Year-over-year growth 2021-2026 (%)
- 8.12 China - Market size and forecast 2021-2026
- Exhibit 108: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 109: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 110: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 111: Data Table on China - Year-over-year growth 2021-2026 (%)
- 8.13 Market opportunity by geography
- Exhibit 112: Market opportunity by geography ($ million)
9 Drivers, Challenges, and Trends
- 9.1 Market drivers
- 9.2 Market challenges
- 9.3 Impact of drivers and challenges
- Exhibit 113: Impact of drivers and challenges in 2021 and 2026
- 9.4 Market trends
10 Vendor Landscape
- 10.1 Overview
- 10.2 Vendor landscape
- Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
- 10.3 Landscape disruption
- Exhibit 115: Overview on factors of disruption
- 10.4 Industry risks
- Exhibit 116: Impact of key risks on business
11 Vendor Analysis
- 11.1 Vendors covered
- Exhibit 117: Vendors covered
- 11.2 Market positioning of vendors
- Exhibit 118: Matrix on vendor position and classification
- 11.3 Abbott Laboratories
- Exhibit 119: Abbott Laboratories - Overview
- Exhibit 120: Abbott Laboratories - Business segments
- Exhibit 121: Abbott Laboratories - Key news
- Exhibit 122: Abbott Laboratories - Key offerings
- Exhibit 123: Abbott Laboratories - Segment focus
- 11.4 Becton Dickinson and Co.
- Exhibit 124: Becton Dickinson and Co. - Overview
- Exhibit 125: Becton Dickinson and Co. - Business segments
- Exhibit 126: Becton Dickinson and Co. - Key news
- Exhibit 127: Becton Dickinson and Co. - Key offerings
- Exhibit 128: Becton Dickinson and Co. - Segment focus
- 11.5 Danaher Corp.
- Exhibit 129: Danaher Corp. - Overview
- Exhibit 130: Danaher Corp. - Business segments
- Exhibit 131: Danaher Corp. - Key news
- Exhibit 132: Danaher Corp. - Key offerings
- Exhibit 133: Danaher Corp. - Segment focus
- 11.6 F. Hoffmann La Roche Ltd.
- Exhibit 134: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 135: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 136: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 137: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 138: F. Hoffmann La Roche Ltd. - Segment focus
- 11.7 PerkinElmer Inc.
- Exhibit 139: PerkinElmer Inc. - Overview
- Exhibit 140: PerkinElmer Inc. - Business segments
- Exhibit 141: PerkinElmer Inc. - Key news
- Exhibit 142: PerkinElmer Inc. - Key offerings
- Exhibit 143: PerkinElmer Inc. - Segment focus
- 11.8 PTS Diagnostics
- Exhibit 144: PTS Diagnostics - Overview
- Exhibit 145: PTS Diagnostics - Product / Service
- Exhibit 146: PTS Diagnostics - Key offerings
- 11.9 QIAGEN NV
- Exhibit 147: QIAGEN NV - Overview
- Exhibit 148: QIAGEN NV - Product / Service
- Exhibit 149: QIAGEN NV - Key news
- Exhibit 150: QIAGEN NV - Key offerings
- 11.10 Sekisui Chemical Co. Ltd.
- Exhibit 151: Sekisui Chemical Co. Ltd. - Overview
- Exhibit 152: Sekisui Chemical Co. Ltd. - Business segments
- Exhibit 153: Sekisui Chemical Co. Ltd. - Key offerings
- Exhibit 154: Sekisui Chemical Co. Ltd. - Segment focus
- 11.11 Siemens AG
- Exhibit 155: Siemens AG - Overview
- Exhibit 156: Siemens AG - Business segments
- Exhibit 157: Siemens AG - Key news
- Exhibit 158: Siemens AG - Key offerings
- Exhibit 159: Siemens AG - Segment focus
- 11.12 Trinity Biotech Plc
- Exhibit 160: Trinity Biotech Plc - Overview
- Exhibit 161: Trinity Biotech Plc - Product / Service
- Exhibit 162: Trinity Biotech Plc - Key offerings
12 Appendix
- 12.1 Scope of the report
- 12.2 Inclusions and exclusions checklist
- Exhibit 163: Inclusions checklist
- Exhibit 164: Exclusions checklist
- 12.3 Currency conversion rates for US$
- Exhibit 165: Currency conversion rates for US$
- 12.4 Research methodology
- Exhibit 166: Research methodology
- Exhibit 167: Validation techniques employed for market sizing
- Exhibit 168: Information sources
- 12.5 List of abbreviations
- Exhibit 169: List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Frequently Asked Questions?
- US
- Canada
- Germany
- UK
- Japan
- China
- Growing geriatric population
- Technological advances in diagnostics
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
